The mission ofthe Oncology Medical Informatics and Services (OMIS) Shared Resource is to provide centralized informatics and software support with data management and analytics services to support the Masonic Cancer Center (MCC) as well as the research projects of all of its members. OMIS develops and supports database applications to provide research data management for all clinical and basic research activities in the MCC. Services include data integration, custom reporting and data set generation, grant support, database application design, development and support, and registry creation. The OMIS Shared Resource provides a critical function not currently available through the University of Minnesota Clinical and Translational Science Institute (CTSI) or the Academic Health Center. OMIS is led by Dr. Sarah Cooley, an Assistant Professor in the Division of Hematology, Oncology, and Transplantation who also serves as the Director of Clinical Research Information (a joint appointment between the University of Minnesota CTSI and Biomedical Health Informatics program) to play a key role in helping the Academic Health Center develop system-wide processes to integrate clinical and genomic data to support translational research and clinical research and personalized medicine. The OMIS group consists of a Senior Manager and a team of 9 full-time staff including, 4 programmer/database administrators, 2 research data analysts, 1 software developer, 1 data architect, and 1 informatics project manager. OMIS provides consultation free of charge to all MCC members to help prepare the informatics resource sections for grant applications and to provide initial cost estimates for other informatics projects. In addition to supporting the administrative needs ofthe MCC, the Resource supports significant database applications used by the Translational Therapy Laboratory (MSC-LIMS), the Clinical Trials Office (OnCore), and the Transplant Biology and Therapy Research Program (BMT Database). The OMIS Resource also supports NIH-funded projects from researchers from 3 of the MCC Research Programs and projects funded by other sources in 2 additional Research Programs. The services and expertise provided by this Shared Resource are critical to the clinical research mission of the MCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA077598-16
Application #
8633126
Study Section
Subcommittee G - Education (NCI)
Project Start
1998-06-01
Project End
2019-01-31
Budget Start
2014-03-05
Budget End
2015-01-31
Support Year
16
Fiscal Year
2014
Total Cost
$284,402
Indirect Cost
$61,605
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Abbott, Kenneth L; Nyre, Erik T; Abrahante, Juan et al. (2015) The Candidate Cancer Gene Database: a database of cancer driver genes from forward genetic screens in mice. Nucleic Acids Res 43:D844-8
Yee, Douglas (2015) A tale of two receptors: insulin and insulin-like growth factor signaling in cancer. Clin Cancer Res 21:667-9
Daniel, A R; Gaviglio, A L; Knutson, T P et al. (2015) Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene 34:506-15
Upadhyaya, Pramod; Hecht, Stephen S (2015) Quantitative analysis of 3'-hydroxynorcotinine in human urine. Nicotine Tob Res 17:524-9
Patel, Yesha M; Stram, Daniel O; Wilkens, Lynne R et al. (2015) The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populations. Cancer Epidemiol Biomarkers Prev 24:119-27
Takahashi, Yutaka; Hui, Susanta K (2014) Fast, simple, and informative patient-specific dose verification method for intensity modulated total marrow irradiation with helical tomotherapy. Radiat Oncol 9:34
Cooley, Sarah; Weisdorf, Daniel J; Guethlein, Lisbeth A et al. (2014) Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia. J Immunol 192:4592-600
Chen, Liddy M; Ibrahim, Joseph G; Chu, Haitao (2014) Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses. J Biopharm Stat 24:817-33
Landman, Sean R; Hwang, Tae Hyun; Silverstein, Kevin A T et al. (2014) SHEAR: sample heterogeneity estimation and assembly by reference. BMC Genomics 15:84
Gates, Leah A; Phillips, Martin B; Matter, Brock A et al. (2014) Comparative metabolism of furan in rodent and human cryopreserved hepatocytes. Drug Metab Dispos 42:1132-6

Showing the most recent 10 out of 319 publications